November 14, 2025

Epilepsy Trends: Do Long-Term Outcomes Improve?

Researchers found seizure reductions over time in patients with focal treatment-resistant epilepsy.

Conexiant

November 13, 2025

‘FDA Said Yes, Despite Inconclusive Evidence’

The FDA’s authorization of the Q-Collar is under scrutiny after researchers identified duplicated data, altered study endpoints, and unsubstantiated “brain protection” claims.

Conexiant

November 12, 2025

AVM Hemorrhage Risk: Is It Time to Rethink the Data?

Researchers redefine the true hemorrhage risk of unruptured brain arteriovenous malformations.

Conexiant

November 11, 2025

Advancing Gene Therapy for Canavan Disease

Interim results from a clinical trial addressing a fatal brain matter disorder suggest that gene therapy could be an effective approach

The Medicine Maker

November 05, 2025

Shame in Medicine—A Quiet Epidemic

A new movement in medicine aims to teach “shame competence,” helping physicians recognize and manage one of the field’s most corrosive yet overlooked emotions.

KFF Health News

November 03, 2025

New Hope for High-Risk MS Patients

A new study outlines a molecular timeline of myelin and axonal injury that may support earlier detection in high-risk patients

The Pathologist

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 27, 2025

Myelin Injury Detected Years Before MS Symptoms

Serum proteins show early immune activity years before multiple sclerosis symptoms appear.

Conexiant

October 22, 2025

FDA Redefining Depression Treatment with New Approvals?

Researchers analyze FDA-approved and Phase 3 antidepressants from 2009 to 2025.

Conexiant